← Back to Search

Salivary insulin responses to mixed meal tolerance test for Insulin Resistance

N/A
Waitlist Available
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured for 90 minutes following the meal (time points: fasting, 60 minutes, and 90 minutes)
Awards & highlights

Study Summary

This trial is looking at whether measuring saliva insulin levels could be a helpful way to understand how different foods impact insulin levels in people of different weights, which could then aid in personalized weight loss advice.

Eligible Conditions
  • Insulin Resistance
  • Diet Modification
  • Hyperinsulinemia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured for 90 minutes following the meal (time points: fasting, 60 minutes, and 90 minutes)
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured for 90 minutes following the meal (time points: fasting, 60 minutes, and 90 minutes) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Saliva insulin area under the curve
Saliva insulin at different time points
Secondary outcome measures
Glucose
Glucose area under the curve

Trial Design

1Treatment groups
Experimental Treatment
Group I: Salivary insulin responses to mixed meal tolerance testExperimental Treatment1 Intervention
Saliva samples and finger prick glucose will be collected after at least 4 hours of fasting and then at 60 and 90 minutes following ingestion of a standardized meal tolerance test.

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,413 Previous Clinical Trials
2,466,811 Total Patients Enrolled
1 Trials studying Insulin Resistance
16 Patients Enrolled for Insulin Resistance
Core-Health Technologies Inc.UNKNOWN
MitacsIndustry Sponsor
38 Previous Clinical Trials
4,211 Total Patients Enrolled
2 Trials studying Insulin Resistance
23 Patients Enrolled for Insulin Resistance

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~24 spots leftby Apr 2025